Sylvie Louise Grégoire is a Canadian businessperson who founded EIP Pharma, Inc. and who has been the head of 6 different companies. Currently, she holds the position of Chairman for Corvidia Therapeutics, Inc. and Executive Chairman at EIP Pharma, Inc.
She is also on the board of PerkinElmer, Inc. (United States), Novo Nordisk An and Shire Orphan Therapies GmbH.
Dr. Grégoire previously occupied the position of Chairman for Metriopharm AG, Executive Vice President-Business Development of Biogen, Inc. and Executive Vice President-Technical Operations at Biogen MA, Inc. (a subsidiary of Biogen, Inc.), Executive Chairman at IDM Pharma, Inc., President, CEO & Executive Director at GlycoFi, Inc., President for Shire Human Genetic Therapies, Inc. and President-Human Genetic Therapies Division at Shire Plc.
Dr. Grégoire received an undergraduate degree from Université Laval and a doctorate from State University of New York at Buffalo.